Relevium Medical Analysis
What is Relevium Medical?
Relevium Medical develops innovative biopharmaceutical treatments for chronic pain, utilizing natural biopolymers combined with pharmacologically active agents to enhance patient care.
Employees
5
Founded
2019
Revenue
$5M
Company Stage
Series A
YC Batch
S22
Product Features & Capabilities
- pharmacological hydrogel treatments for chronic pain, injectable gel for knee osteoarthritis, innovative therapies integrating natural biopolymers, focus on debilitating chronic pain conditions, development of novel pharmacological gel candidates.
Who are the founders of Relevium Medical
AL
Alison Liddy
Founder, CEO
Market Focus
Relevium Medical primarily focuses on the biopharmaceutical industry, specifically on developing innovative treatments for chronic pain conditions by integrating natural biopolymers with pharmacologically active agents.
Business Model
Revenue from clinical trials, partnerships, and government funding for treatment development.
Competitors Overview
Relevium Medical operates in the biopharmaceutical sector, focusing on innovative treatments for chronic pain. Its main competitors include:
- PIQUR Therapeutics: This company is primarily focused on oncology and does not have a specific emphasis on chronic pain treatments. Their pipeline incl
Investors
- Y Combinator
- Disruptive Technologies Innovation Fund
- Enterprise Ireland
See something that needs updating? Suggest edits to this profile.